厄瓜多尔32型序列中的新德里金属β-内酰胺酶-1（NDM-1）碳青霉烯酶
NDM-1 carbapenemase in sequence type 32 in Ecuador.
作者信息
Villacís J E, Bovera M, Romero-Alvarez D, Cornejo F, Albán V, Trueba G, Dorn H F, Reyes J A
机构信息
Carrera de Bioquímica Clínica, Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
Centro de Referencia Nacional de Resistencia a los Antimicrobianos Instituto Nacional de Investigación en Salud Pública 'Leopoldo Izquieta Pérez', Quito, Ecuador.
出版信息
New Microbes New Infect. 2019 Mar 8;29:100526. doi: 10.1016/j.nmni.2019.100526. eCollection 2019 May.
Abstract
OBJECTIVES
To describe a clinical case of sequence type (ST) 32 harbouring a New Delhi metallo-β-lactamase (NDM) in Ecuador.
METHODS
We used multilocus sequence typing (MLST) to confirm the bacterial species and the sequence type of an isolate. We used synergy with the imipenem-EDTA disc method and the carbapenem inactivation method (CIM) to determine carbapenemase production; the presence of a carbapenemase gene was confirmed by PCR amplification and amplicon sequencing.
RESULTS
Molecular characterization revealed the presence of . ST32 harbouring the gene in Ecuador. The gene was isolated through PCR and amplified from a purified plasmid.
CONCLUSIONS
To the best of our knowledge, this is the first report of . ST32 harbouring the gene.
摘要
目的
描述在厄瓜多尔发现的携带新德里金属β-内酰胺酶（NDM）的序列类型（ST）32的临床病例。
方法
我们使用多位点序列分型（MLST）来确认分离株的细菌种类和序列类型。我们采用亚胺培南-EDTA纸片协同法和碳青霉烯酶灭活法（CIM）来确定碳青霉烯酶的产生；通过PCR扩增和扩增子测序确认碳青霉烯酶基因的存在。
结果
分子特征显示在厄瓜多尔存在携带该基因的ST32。该基因通过PCR从纯化质粒中分离并扩增得到。
结论
据我们所知，这是首次报道携带该基因的ST32。
相似文献
1
NDM-1 carbapenemase in sequence type 32 in Ecuador.
New Microbes New Infect. 2019 Mar 8;29:100526. doi: 10.1016/j.nmni.2019.100526. eCollection 2019 May.
2
Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.
J Antimicrob Chemother. 2011 Sep;66(9):1998-2001. doi: 10.1093/jac/dkr256. Epub 2011 Jun 21.
3
First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals.
J Infect Chemother. 2014 Nov;20(11):696-701. doi: 10.1016/j.jiac.2014.07.010. Epub 2014 Sep 16.
4
Early detection of metallo-β-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals.
Int J Antimicrob Agents. 2016 Jul;48(1):46-50. doi: 10.1016/j.ijantimicag.2016.03.007. Epub 2016 Apr 25.
5
Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia.
Int J Antimicrob Agents. 2018 Dec;52(6):916-921. doi: 10.1016/j.ijantimicag.2018.05.017. Epub 2018 May 30.
6
Phenotypic and genotypic characterization of carbapenem-resistant isolates from Egypt.
Antimicrob Resist Infect Control. 2019 Nov 20;8:185. doi: 10.1186/s13756-019-0611-6. eCollection 2019.
7
First detection of a plasmid-encoded New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Acinetobacter baumannii using whole genome sequencing, isolated in a clinical setting in Benin.
Ann Clin Microbiol Antimicrob. 2021 Jan 6;20(1):5. doi: 10.1186/s12941-020-00411-w.
8
Emergence of NDM-producing non-baumannii Acinetobacter spp. isolated from China.
Eur J Clin Microbiol Infect Dis. 2014 May;33(5):853-60. doi: 10.1007/s10096-013-2024-4. Epub 2013 Dec 5.
9
Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles.
J Antimicrob Chemother. 2017 Aug 1;72(8):2201-2207. doi: 10.1093/jac/dkx131.
10
Co-occurrence of blaNDM-1 with blaOXA-23 or blaOXA-58 in clinical multidrug-resistant Acinetobacter baumannii isolates in Algeria.
J Glob Antimicrob Resist. 2016 Sep;6:136-141. doi: 10.1016/j.jgar.2016.05.003. Epub 2016 Jun 11.
引用本文的文献
1
Genomic analysis of early ST32 Acinetobacter baumannii strains recovered in US military treatment facilities reveals distinct lineages and links to the origins of the Tn6168 ampC transposon.
J Antimicrob Chemother. 2025 Mar 3;80(3):666-675. doi: 10.1093/jac/dkae454.
2
Carbapenem Resistance in Complex Isolates From Kathmandu Model Hospital, Nepal, Is Attributed to the Presence of and Genes.
Biomed Res Int. 2024 Aug 12;2024:8842625. doi: 10.1155/2024/8842625. eCollection 2024.
3
Genomic study of strains co-harboring and reveals a large multidrug-resistant plasmid encoding these carbapenemases in Brazil.
Front Microbiol. 2024 Jul 17;15:1439373. doi: 10.3389/fmicb.2024.1439373. eCollection 2024.
4
Carbapenemase genes in clinical and environmental isolates of spp. from Quito, Ecuador.
PeerJ. 2024 Apr 25;12:e17199. doi: 10.7717/peerj.17199. eCollection 2024.
5
Myrtenol Inhibits Biofilm Formation and Virulence in the Drug-Resistant : Insights into the Molecular Mechanisms.
Infect Drug Resist. 2022 Sep 2;15:5137-5148. doi: 10.2147/IDR.S379212. eCollection 2022.
6
Detection of NDM-1-Positive from Bacteremia by Using Whole-Genome Sequencing.
Infect Drug Resist. 2022 Jun 2;15:2835-2841. doi: 10.2147/IDR.S360353. eCollection 2022.
7
First detection of a plasmid-encoded New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Acinetobacter baumannii using whole genome sequencing, isolated in a clinical setting in Benin.
Ann Clin Microbiol Antimicrob. 2021 Jan 6;20(1):5. doi: 10.1186/s12941-020-00411-w.
8
The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates.
Antimicrob Resist Infect Control. 2020 Jul 6;9(1):101. doi: 10.1186/s13756-020-00769-8.
9
Efficacy of pulsed-xenon ultraviolet light for disinfection of high-touch surfaces in an Ecuadorian hospital.
BMC Infect Dis. 2019 Jul 3;19(1):575. doi: 10.1186/s12879-019-4200-3.
本文引用的文献
1
First case of New Delhi metallo-β-lactamase in Klebsiella pneumoniae from Ecuador: An update for South America.
Int J Infect Dis. 2017 Dec;65:119-121. doi: 10.1016/j.ijid.2017.10.012. Epub 2017 Dec 1.
2
Genomic Epidemiology of NDM-1-Encoding Plasmids in Latin American Clinical Isolates Reveals Insights into the Evolution of Multidrug Resistance.
Genome Biol Evol. 2017 Jun 1;9(6):1725-1741. doi: 10.1093/gbe/evx115.
3
The epidemiology of carbapenemases in Latin America and the Caribbean.
Expert Rev Anti Infect Ther. 2017 Mar;15(3):277-297. doi: 10.1080/14787210.2017.1268918. Epub 2016 Dec 20.
4
First case of NDM-1-producing Providencia rettgeri in Ecuador.
J Glob Antimicrob Resist. 2015 Dec;3(4):302-303. doi: 10.1016/j.jgar.2015.07.003. Epub 2015 Aug 7.
5
Complete Sequence of a bla(NDM-1)-Harboring Plasmid in an Acinetobacter bereziniae Clinical Strain Isolated in Argentina.
Antimicrob Agents Chemother. 2015 Oct;59(10):6667-9. doi: 10.1128/AAC.00367-15. Epub 2015 Jul 27.
6
Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria.
Biomed Res Int. 2014;2014:249856. doi: 10.1155/2014/249856. Epub 2014 Mar 26.
7
Characterization of a novel international clonal complex (CC32) of Acinetobacter baumannii with epidemic potential.
Epidemiol Infect. 2014 Jul;142(7):1554-8. doi: 10.1017/S0950268813002288. Epub 2013 Sep 30.
8
ISAba825 controls the expression of the chromosomal bla(OXA-51-like) and the plasmid borne bla(OXA-58) gene in clinical isolates of Acinetobacter baumannii isolated from the USA.
Clin Microbiol Infect. 2012 Nov;18(11):E446-51. doi: 10.1111/j.1469-0691.2012.03979.x. Epub 2012 Aug 3.
9
Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.
Lancet Infect Dis. 2011 May;11(5):355-62. doi: 10.1016/S1473-3099(11)70059-7. Epub 2011 Apr 7.
10
Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India.
J Antimicrob Chemother. 2010 Oct;65(10):2253-4. doi: 10.1093/jac/dkq273. Epub 2010 Jul 21.
Zotero 插件